Seeking Alpha

Bacterin pre-announces strong Q1

Bacterin (BONE) expects Q1 revenue of $8.7M-$8.9M, +7% Q/Q and +2% Y/Y, and above an $8.5M consensus.

Core recurring Biologics revenue (excludes stocking orders) are expected to total $8.55M-$8.65M, up 7% Q/Q and 20% Y/Y.

Full Q1 results are due on May 6.

Comments (4)
  • PharmSterZzZ
    , contributor
    Comments (253) | Send Message
    is this a trick?
    21 Apr 2014, 07:32 PM Reply Like
  • Andre LaPlume
    , contributor
    Comments (464) | Send Message
    Care to explain?
    21 Apr 2014, 08:15 PM Reply Like
  • SteMaj
    , contributor
    Comments (5) | Send Message
    looks promising :)
    22 Apr 2014, 06:26 AM Reply Like
  • docinfl
    , contributor
    Comment (1) | Send Message
    The financial chart shows a historical repeat. Two weeks prior to the earnings announcement the stock climbs.
    We are two weeks away now and there is some good news already. Soon there will be more attention and the stock will jump. It will probably rise up 20 cents from todays close over the next two weeks. If the company does well from the earnings then they can continue to climb.
    22 Apr 2014, 05:40 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs